雌激素及其受体对骨质疏松症影响的研究进展  

Research advance of the effect of estrogen on osteoporosis

作　　者：章时珍[1] 汪煌[1] 段斌斌[1] 史晓林 

机构地区：[1]浙江中医药大学,杭州310053 [2]浙江中医医药大学附属第二医院

出　　处：《中国骨质疏松杂志》2011年第5期453-456,共4页Chinese Journal of Osteoporosis

基　　金：浙江省大学生科技创新活动计划(新苗人才计划)项目(2010ZB033)

摘　　要：骨质疏松症(osteoporosis)是一种全身性骨量减少及骨组织微结构改变,从而导致骨脆性增加及易发生骨折的一种常见的、全身性的骨代谢疾病。其致病因素很多,现在认为雌激素水平是影响女性骨密度的重要因素,雌激素缺乏是公认的骨质疏松症的重要诱因之一。雌激素的效应主要通过雌激素受体来发挥。本文就雌激素及其受体对骨质疏松症的影响做一阐述。Osteoporosis is a common systemic bone metabolic disease, which is caused by the decrease of the whole bone mass and by the change of the bone microstrueture, resulting in an increase on bone frigility and risk of fracture. There are many pathogenic factors. It is believed that estrogen level is the most important factor to influence bone mineral density in the female. Estrogen deficiency is widely accepted as one of the most important induction factor of osteoporosis. The article will state comprehensively about the effect of estrogen on osteoporosis.

关 键 词：雌激素 骨质疏松症 雌激素受体 

分 类 号：R681[医药卫生—骨科学]